Hongbing Wang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Positive Breast Cancer

Top Venues

Hepatology communications

Molecular pharmacology

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Kaiyan Liu, Zhihui Li, Linhao Li, Scott Heyward, Shelley R Wang, Ling He, Hongbing Wang
Mechanistic understanding of dexamethasone-mediated protection against remdesivir-induced hepatotoxicity . Molecular pharmacology (2024)
Kaiyan Liu, Zhihui Li, Linhao Li, Scott Heyward, Shelley R Wang, Ling He, Hongbing Wang
Mechanistic understanding of dexamethasone-mediated protection against remdesivir-induced hepatotoxicity . Molecular pharmacology (2024)
Kaiyan Liu, Zhihui Li, Linhao Li, Scott Heyward, Shelley R Wang, Ling He, Hongbing Wang
Mechanistic Understanding of Dexamethasone-Mediated Protection against Remdesivir-Induced Hepatotoxicity. Molecular pharmacology 106 (1) (2024)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Sydney Stern, Hongbing Wang, Nakissa Sadrieh
Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI. Cells 12 (11) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Melissa Metry, Samuel A Krug, Vijaya Kumari Karra, Maureen A Kane, Jeffrey C Fink, Yan Shu, Hongbing Wang, James E Polli
Differential effects of metformin-mediated BSEP repression on pravastatin and bile acid pharmacokinetics in humans: A randomized controlled trial. Clinical and translational science 15 (10) (2022)
Shuaiqian Men, Hongbing Wang
Phenobarbital in Nuclear Receptor Activation: an update. Drug metabolism and disposition: the biological fate of chemicals (2022)
William D Hedrich, Hongbing Wang
Friend or Foe: Xenobiotic Activation of Nrf2 in Disease Control and Cardioprotection. Pharmaceutical research 38 (2) (2021)
Zhihui Li, Hongbing Wang
Molecular Mechanisms of the SLC13A5 Gene Transcription. Metabolites 11 (10) (2021)
Zhihui Li, Linhao Li, Scott Heyward, Shuaiqian Men, Meishu Xu, Tatsuya Sueyoshi, Hongbing Wang
Phenobarbital Induces SLC13A5 Expression through Activation of PXR but Not CAR in Human Primary Hepatocytes. Cells 10 (12) (2021)
Brandy Garzel, Tao Hu, Linhao Li, Yuanfu Lu, Scott Heyward, James Polli, Lei Zhang, Shiew-Mei Huang, Jean-Pierre Raufman, Hongbing Wang
Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression. Pharmaceutical research 37 (2) (2020)